Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis.

Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Abou-El-Ardat K, Kiefer KC, Hoffmann J, Seeger F, Bonig H, Dimmeler S, Zeiher AM, Rieger MA.

Haematologica. 2019 Nov 7. pii: haematol.2019.224402. doi: 10.3324/haematol.2019.224402. [Epub ahead of print]

2.

Minimally invasive embolectomy of HeartWare left ventricular assist device outflow graft.

Mutlak H, Assmus B, Popov AF.

J Thorac Dis. 2019 Apr;11(Suppl 6):S957-S959. doi: 10.21037/jtd.2019.03.82. No abstract available.

3.

Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.

Ortmann CA, Dorsheimer L, Abou-El-Ardat K, Hoffrichter J, Assmus B, Bonig H, Scholz A, Pfeifer H, Martin H, Schmid T, Brüne B, Scheich S, Steffen B, Riemann J, Hermann S, Dukat A, Bug G, Brandts CH, Wagner S, Serve H, Rieger MA.

Cell Rep. 2019 May 14;27(7):2022-2028.e3. doi: 10.1016/j.celrep.2019.04.064.

4.

Neonatal myocardial infarction: substantial improvement of cardiac function after autologous bone marrow-derived cell therapy.

Zschirnt M, Jux C, Boenig H, Zeiher A, Assmus B, Khalil M, Kriebel T, Rupp S.

Clin Res Cardiol. 2019 Nov;108(11):1309-1311. doi: 10.1007/s00392-019-01478-y. Epub 2019 Apr 26. No abstract available.

PMID:
31028476
5.

Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis.

von Jeinsen B, Sopova K, Palapies L, Leistner DM, Fichtlscherer S, Seeger FH, Honold J, Dimmeler S, Aßmus B, Zeiher AM, Keller T.

ESC Heart Fail. 2019 Jun;6(3):536-544. doi: 10.1002/ehf2.12416. Epub 2019 Mar 25.

6.

SPRED2 deficiency elicits cardiac arrhythmias and premature death via impaired autophagy.

Ullrich M, Aßmus B, Augustin AM, Häbich H, Abeßer M, Martin Machado J, Werner F, Erkens R, Arias-Loza AP, Umbenhauer S, Wagner H, Benz PM, Unger A, Linke WA, Frantz S, Baba HA, Kuhn M, Schuh K.

J Mol Cell Cardiol. 2019 Apr;129:13-26. doi: 10.1016/j.yjmcc.2019.01.023. Epub 2019 Feb 13.

PMID:
30771306
7.

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.

Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K, Schmid T, Brüne B, Wagner S, Serve H, Hoffmann J, Seeger F, Dimmeler S, Zeiher AM, Rieger MA.

JAMA Cardiol. 2019 Jan 1;4(1):25-33. doi: 10.1001/jamacardio.2018.3965.

8.

[Pulmonary artery pressure sensor for ambulatory assessment of ventricular filling pressure in advanced heart failure : What should be considered for the follow-up care?]

Herrmann E, Ecke A, Fichtlscherer S, Zeiher AM, Assmus B.

Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):393-400. doi: 10.1007/s00399-018-0597-4. Epub 2018 Oct 10. Review. German.

PMID:
30306304
9.

Daily non-invasive haemodynamic telemonitoring for efficacy evaluation of MitraClip® implantation in patients with advanced systolic heart failure.

Herrmann E, Ecke A, Herrmann E, Eissing N, Fichtlscherer S, Zeiher AM, Assmus B.

ESC Heart Fail. 2018 Oct;5(5):780-787. doi: 10.1002/ehf2.12303. Epub 2018 Jun 12.

10.

Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Angermann CE, Assmus B, Anker SD, Brachmann J, Ertl G, Köhler F, Rosenkranz S, Tschöpe C, Adamson PB, Böhm M.

Clin Res Cardiol. 2018 Nov;107(11):991-1002. doi: 10.1007/s00392-018-1281-8. Epub 2018 May 19.

PMID:
29777373
11.

Percutaneous Therapy of a Stenotic Parachute Mitral Valve Previously Treated by Surgery.

De Rosa R, Schranz D, Vasa-Nicotera M, Assmus B, Risteski P, Moritz A, Zeiher AM, Fichtlscherer S.

J Heart Valve Dis. 2017 Jul;26(4):488-491.

PMID:
29302951
12.

The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial.

Mathur A, Arnold R, Assmus B, Bartunek J, Belmans A, Bönig H, Crea F, Dimmeler S, Dowlut S, Fernández-Avilés F, Galiñanes M, Garcia-Dorado D, Hartikainen J, Hill J, Hogardt-Noll A, Homsy C, Janssens S, Kala P, Kastrup J, Martin J, Menasche P, Miklik R, Mozid A, San Román JA, Sanz-Ruiz R, Tendera M, Wojakowski W, Ylä-Herttuala S, Zeiher A.

Eur J Heart Fail. 2017 Nov;19(11):1545-1550. doi: 10.1002/ejhf.829. Epub 2017 Sep 25.

13.

Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry.

Luu B, Leistner DM, Herrmann E, Seeger FH, Honold J, Fichtlscherer S, Zeiher AM, Assmus B.

Circ Res. 2017 Jun 9;120(12):1938-1946. doi: 10.1161/CIRCRESAHA.116.309938. Epub 2017 Mar 28.

PMID:
28351842
14.

[Implantable sensors for outpatient assessment of ventricular filling pressure in advanced heart failure : Which telemonitoring design is optimal?]

Herrmann E, Fichtlscherer S, Hohnloser SH, Zeiher AM, Aßmus B.

Herzschrittmacherther Elektrophysiol. 2016 Dec;27(4):371-377. Epub 2016 Nov 14. Review. German.

PMID:
27844194
15.

Responder Definition in Clinical Stem Cell Trials in Cardiology: Will the Real Responder Please Stand Up?

Zwetsloot PP, Gremmels H, Assmus B, Koudstaal S, Sluijter JP, Zeiher AM, Chamuleau SA.

Circ Res. 2016 Aug 5;119(4):514-8. doi: 10.1161/CIRCRESAHA.116.308733. Review. No abstract available.

PMID:
27492842
16.

Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.

Derlet A, Rasper T, Roy Choudhury A, Bothur S, Rieger MA, Namgaladze D, Fischer A, Schürmann C, Brandes RP, Tschulena U, Steppan S, Assmus B, Dimmeler S, Zeiher AM, Seeger FH.

Stem Cells. 2016 Aug;34(8):2236-48. doi: 10.1002/stem.2394. Epub 2016 May 25.

17.

Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT.

Assmus B, Alakmeh S, De Rosa S, Bönig H, Hermann E, Levy WC, Dimmeler S, Zeiher AM.

Eur Heart J. 2016 Jun 1;37(21):1659-66. doi: 10.1093/eurheartj/ehv559. Epub 2015 Oct 29.

18.

Percutaneous SAPIEN S3 Transcatheter Valve Implantation for Post-Left Ventricular Assist Device Aortic Regurgitation.

Kornberger A, Beiras-Fernandez A, Fichtlscherer S, Assmus B, Moritz A, Stock UA.

Ann Thorac Surg. 2015 Oct;100(4):e67-9. doi: 10.1016/j.athoracsur.2015.06.089.

PMID:
26434481
19.

Suspected involvement of EPTFE membrane in sterile intrathoracic abscess and pericardial empyema in a multi-allergic LVAD recipient: a case report.

Kornberger A, Walter V, Khalil M, Therapidis P, Assmus B, Moritz A, Beiras-Fernandez A, Stock UA.

J Cardiothorac Surg. 2015 Jul 17;10:99. doi: 10.1186/s13019-015-0305-y.

20.

Cardiac cell therapy: lost in meta-analyses.

Assmus B, Dimmeler S, Zeiher AM.

Circ Res. 2015 Apr 10;116(8):1291-2. doi: 10.1161/CIRCRESAHA.115.306330. No abstract available.

PMID:
25858060
21.

Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.

Gyöngyösi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, Marban E, Assmus B, Henry TD, Traverse JH, Moyé LA, Sürder D, Corti R, Huikuri H, Miettinen J, Wöhrle J, Obradovic S, Roncalli J, Malliaras K, Pokushalov E, Romanov A, Kastrup J, Bergmann MW, Atsma DE, Diederichsen A, Edes I, Benedek I, Benedek T, Pejkov H, Nyolczas N, Pavo N, Bergler-Klein J, Pavo IJ, Sylven C, Berti S, Navarese EP, Maurer G; ACCRUE Investigators.

Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.

22.

The challenges of autologous cell therapy: systemic anti-thrombotic therapies interfering with serum coagulation may disable autologous serum-containing cell products for therapeutical use.

Seeger FH, Rasper T, Bönig H, Assmus B, Zeiher AM, Dimmeler S.

J Cardiovasc Transl Res. 2014 Oct;7(7):644-50. doi: 10.1007/s12265-014-9584-2. Epub 2014 Sep 13.

PMID:
25217035
23.

Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.

Assmus B, Leistner DM, Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Sedding D, Yu J, Corti R, Mathey DG, Barth C, Mayer-Wehrstein C, Burck I, Sueselbeck T, Dill T, Hamm CW, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Study Group.

Eur Heart J. 2014 May 14;35(19):1275-83. doi: 10.1093/eurheartj/ehu062. Epub 2014 Feb 25.

PMID:
24569031
24.

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.

Delewi R, Hirsch A, Tijssen JG, Schächinger V, Wojakowski W, Roncalli J, Aakhus S, Erbs S, Assmus B, Tendera M, Goekmen Turan R, Corti R, Henry T, Lemarchand P, Lunde K, Cao F, Huikuri HV, Sürder D, Simari RD, Janssens S, Wollert KC, Plewka M, Grajek S, Traverse JH, Zijlstra F, Piek JJ.

Eur Heart J. 2014 Apr;35(15):989-98. doi: 10.1093/eurheartj/eht372. Epub 2013 Sep 11. Review.

25.

Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.

Honold J, Fischer-Rasokat U, Seeger FH, Leistner D, Lotz S, Dimmeler S, Zeiher AM, Assmus B.

Clin Res Cardiol. 2013 Sep;102(9):619-25. doi: 10.1007/s00392-013-0574-1. Epub 2013 Apr 24.

PMID:
23612920
26.

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

Assmus B, Walter DH, Seeger FH, Leistner DM, Steiner J, Ziegler I, Lutz A, Khaled W, Klotsche J, Tonn T, Dimmeler S, Zeiher AM.

JAMA. 2013 Apr 17;309(15):1622-31. doi: 10.1001/jama.2013.3527. Erratum in: JAMA. 2013 May 15;309(19):1994.

PMID:
23592107
27.

Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application.

Honold J, DeRosa S, Spyridopoulos I, Fischer-Rasokat U, Seeger FH, Leistner D, Lotz S, Levy WC, Zeiher AM, Assmus B.

Clin Cardiol. 2013 Mar;36(3):153-9. doi: 10.1002/clc.22093. Epub 2013 Feb 3.

28.

Procedural safety and predictors of acute outcome of intracoronary administration of progenitor cells in 775 consecutive procedures performed for acute myocardial infarction or chronic heart failure.

De Rosa S, Seeger FH, Honold J, Fischer-Rasokat U, Lehmann R, Fichtlscherer S, Schächinger V, Dimmeler S, Zeiher AM, Assmus B.

Circ Cardiovasc Interv. 2013 Feb;6(1):44-51. doi: 10.1161/CIRCINTERVENTIONS.112.971705. Epub 2013 Jan 29.

PMID:
23362308
29.

Extensive dissecting aneurysm of the ascending aorta.

Fox H, Hemmann K, Kerl M, Martens S, Voelkl L, Assmus B.

J Cardiol Cases. 2013 Jan 29;7(4):e97-e100. doi: 10.1016/j.jccase.2012.11.004. eCollection 2013 Apr.

30.

Early cardiac retention of administered stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy.

Assmus B, Zeiher AM.

Circ Res. 2013 Jan 4;112(1):6-8. doi: 10.1161/CIRCRESAHA.112.300341. No abstract available.

PMID:
23287451
31.

G-CSF stimulation and coronary reinfusion of mobilized circulating mononuclear proangiogenic cells in patients with chronic ischemic heart disease:five-year results of the TOPCARE-G-CSF trial.

Honold J, Fischer-Rasokat U, Lehmann R, Leistner DM, Seeger FH, Schachinger V, Martin H, Dimmeler S, Zeiher AM, Assmus B.

Cell Transplant. 2012;21(11):2325-37. doi: 10.3727/096368912X654957. Epub 2012 Sep 7.

PMID:
22963750
32.

Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis.

Leistner DM, Seeger FH, Fischer A, Röxe T, Klotsche J, Iekushi K, Seeger T, Assmus B, Honold J, Karakas M, Badenhoop K, Frantz S, Dimmeler S, Zeiher AM.

Circ Heart Fail. 2012 Nov;5(6):769-77. doi: 10.1161/CIRCHEARTFAILURE.111.966093. Epub 2012 Aug 30.

PMID:
22936827
33.

Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair.

Seeger FH, Rasper T, Fischer A, Muhly-Reinholz M, Hergenreider E, Leistner DM, Sommer K, Manavski Y, Henschler R, Chavakis E, Assmus B, Zeiher AM, Dimmeler S.

Circ Res. 2012 Sep 14;111(7):854-62. doi: 10.1161/CIRCRESAHA.112.265678. Epub 2012 Jul 19.

PMID:
22821930
34.

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.

Xu Q, Seeger FH, Castillo J, Iekushi K, Boon RA, Farcas R, Manavski Y, Li YG, Assmus B, Zeiher AM, Dimmeler S.

J Am Coll Cardiol. 2012 Jun 5;59(23):2107-17. doi: 10.1016/j.jacc.2012.02.033.

35.

[Regenerative treatment of advanced heart disease].

Leistner DM, Seeger FH, Dimmeler S, Zeiher AM, Assmus B.

Dtsch Med Wochenschr. 2012 Apr;137(14):732-7. doi: 10.1055/s-0031-1299037. Epub 2012 Mar 27. Review. German. No abstract available.

PMID:
22454205
36.

Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction.

Iekushi K, Seeger F, Assmus B, Zeiher AM, Dimmeler S.

Circulation. 2012 Apr 10;125(14):1765-73, S1-7. doi: 10.1161/CIRCULATIONAHA.111.079699. Epub 2012 Mar 8.

PMID:
22403243
37.

Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow.

Assmus B, Iwasaki M, Schächinger V, Roexe T, Koyanagi M, Iekushi K, Xu Q, Tonn T, Seifried E, Liebner S, Kranert WT, Grünwald F, Dimmeler S, Zeiher AM.

Eur Heart J. 2012 Aug;33(15):1911-9. doi: 10.1093/eurheartj/ehr388. Epub 2011 Dec 15.

PMID:
22173911
38.

Early remodeling processes as predictors of diastolic function 5 years after reperfused acute myocardial infarction and intracoronary progenitor cell application.

Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Schächinger V, Dimmeler S, Zeiher AM, Assmus B.

Clin Res Cardiol. 2012 Mar;101(3):209-16. doi: 10.1007/s00392-011-0382-4. Epub 2011 Nov 22.

PMID:
22105229
39.

Transcoronary concentration gradients of circulating microRNAs.

De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM.

Circulation. 2011 Nov 1;124(18):1936-44. doi: 10.1161/CIRCULATIONAHA.111.037572. Epub 2011 Oct 3.

PMID:
21969012
40.

Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI.

Rolf A, Assmus B, Schächinger V, Rixe J, Möllmann S, Möllmann H, Dimmeler S, Zeiher AM, Hamm CW, Dill T.

Clin Res Cardiol. 2011 Nov;100(11):983-92. doi: 10.1007/s00392-011-0330-3. Epub 2011 Jun 17.

PMID:
21681619
41.

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.

Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schächinger V, Lehmann R, Martin H, Burck I, Urbich C, Dimmeler S, Zeiher AM, Assmus B.

Clin Res Cardiol. 2011 Oct;100(10):925-34. doi: 10.1007/s00392-011-0327-y. Epub 2011 Jun 3.

PMID:
21633921
42.

Intracoronary administration of bone marrow-derived mononuclear cells and arrhythmic events in patients with chronic heart failure.

Leistner DM, Schmitt J, Palm S, Klotsche J, Estel S, Fink A, Israel CW, Assmus B, Duray GZ, Dimmeler S, Hohnloser SH, Zeiher AM.

Eur Heart J. 2011 Feb;32(4):485-91. doi: 10.1093/eurheartj/ehq430. Epub 2010 Dec 7.

PMID:
21138937
43.

Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.

Assmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J, Schächinger V, Seifried E, Zeiher AM, Dimmeler S.

J Am Coll Cardiol. 2010 Mar 30;55(13):1385-94. doi: 10.1016/j.jacc.2009.10.059.

44.

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.

Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schächinger V; REPAIR-AMI Investigators.

Circ Heart Fail. 2010 Jan;3(1):89-96. doi: 10.1161/CIRCHEARTFAILURE.108.843243. Epub 2009 Dec 8.

PMID:
19996415
45.

Levels of circulating pro-angiogenic cells predict cardiovascular outcomes in patients with chronic heart failure.

Balconi G, Lehmann R, Fiordaliso F, Assmus B, Dimmeler S, Sarto P, Carbonieri E, Gualco A, Campana C, Angelici L, Masson S, Mohammed SA, Dejana E, Gorini M, Zeiher AM, Latini R; GISSI-HF Investigators.

J Card Fail. 2009 Nov;15(9):747-55. doi: 10.1016/j.cardfail.2009.05.011. Epub 2009 Jul 3.

PMID:
19879460
46.

A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.

Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D, Fichtlscherer S, Schächinger V, Tonn T, Martin H, Dimmeler S, Zeiher AM.

Circ Heart Fail. 2009 Sep;2(5):417-23. doi: 10.1161/CIRCHEARTFAILURE.109.855023. Epub 2009 Jul 29.

PMID:
19808371
47.

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial.

Schächinger V, Assmus B, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Yu J, Corti R, Mathey DG, Hamm CW, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI investigators.

Eur J Heart Fail. 2009 Oct;11(10):973-9. doi: 10.1093/eurjhf/hfp113.

49.

Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.

Schächinger V, Aicher A, Döbert N, Röver R, Diener J, Fichtlscherer S, Assmus B, Seeger FH, Menzel C, Brenner W, Dimmeler S, Zeiher AM.

Circulation. 2008 Sep 30;118(14):1425-32. doi: 10.1161/CIRCULATIONAHA.108.777102. Epub 2008 Sep 15.

PMID:
18794392
50.

The initial slope of the VCO2/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction.

Honold J, Geiger L, Assmus B, Fischer-Rasokat U, Schaechinger V, Zeiher AM, Spyridopoulos I.

Clin Res Cardiol. 2008 Dec;97(12):882-90. doi: 10.1007/s00392-008-701-6. Epub 2008 Aug 11.

PMID:
18696021

Supplemental Content

Loading ...
Support Center